2023-08-01 2024-07-31 false Capium Accounts Production 1.1 14209675 2023-08-01 2024-07-31 14209675 bus:AbridgedAccounts 2023-08-01 2024-07-31 14209675 bus:FRS102 2023-08-01 2024-07-31 14209675 bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 14209675 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 14209675 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 14209675 2023-08-01 2024-07-31 14209675 2024-07-31 14209675 bus:RegisteredOffice 2023-08-01 2024-07-31 14209675 core:WithinOneYear 2024-07-31 14209675 core:AfterOneYear 2024-07-31 14209675 1 2023-08-01 2024-07-31 14209675 bus:Director1 2023-08-01 2024-07-31 14209675 bus:Director1 2024-07-31 14209675 bus:Director1 2022-08-01 2023-07-31 14209675 2022-08-01 14209675 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 14209675 2022-08-01 2023-07-31 14209675 2023-07-31 14209675 core:WithinOneYear 2023-07-31 14209675 core:AfterOneYear 2023-07-31 14209675 bus:EntityAccountantsOrAuditors 2022-08-01 2023-07-31 14209675 bus:OrdinaryShareClass1 2023-08-01 2024-07-31 14209675 bus:OrdinaryShareClass1 2024-07-31 14209675 bus:OrdinaryShareClass1 2022-08-01 2023-07-31 14209675 bus:OrdinaryShareClass1 2023-07-31 14209675 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 14209675 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 14209675 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-07-31 14209675 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 14209675 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 14209675 core:Non-currentFinancialInstruments 2024-07-31 14209675 core:Non-currentFinancialInstruments 2023-07-31 14209675 core:ShareCapital 2024-07-31 14209675 core:ShareCapital 2023-07-31 14209675 core:RetainedEarningsAccumulatedLosses 2024-07-31 14209675 core:RetainedEarningsAccumulatedLosses 2023-07-31 14209675 dpl:Item1 2023-08-01 14209675 dpl:Item1 2024-07-31 14209675 dpl:Item1 2022-08-01 14209675 dpl:Item1 2023-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14209675
England and Wales

 

 

 

ZURAIB MEDICS LTD


Abridged Accounts
 


Period of accounts

Start date: 01 August 2023

End date: 31 July 2024
 
 
Notes
 
2024
£
  2023
£
Current assets      
Cash at bank and in hand 140,960    65,428 
Creditors: amount falling due within one year (28,648)   (21,755)
Net current assets 112,312    43,673 
 
Total assets less current liabilities 112,312    43,673 
Net assets 112,312    43,673 
 

Capital and reserves
     
Called up share capital 3 100    100 
Profit and loss account 112,212    43,573 
Shareholders' funds 112,312    43,673 
 


For the year ended 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 13 January 2025 and were signed by:


-------------------------------
Aamir Riaz Awan
Director
1
General Information
Zuraib Medics Ltd is a private company, limited by shares, registered in England and Wales, registration number 14209675, registration address 7 Sorrel Green , Warwick, Warwickshire, CV34 0AE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 1).
3.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

2